Dr Reddy’s close to Canada approval for generic weight loss drug: GV Prasad
Dr Reddy’s close to Canada approval for generic weight loss drug: GV Prasad is drawing significant interest across the industry.
GV Prasad, Co-Chairman & MD, Dr Reddy’s Lab said Canada could offer early market opportunity before competition increases. The company plans launches in multiple markets based on patent and approval status. Dr Reddy’s is focusing on partnerships, biosimilars pipeline expansion and selective global acquisitions to support long-term growth.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Urgent product recall issued for common blood pressure medicine
- Family-friendly travel guide Great Wolf Lodge indoor water park
- Polymarket defends its decision to allow betting on war as ‘invaluable’
- After IDFC fraud disclosure, government deposits may tilt toward PSU banks
Source: Original →